Health ❯ Healthcare ❯ Medication

Side Effects

Gastrointestinal Issues Patient Education Psychopharmacology Overdosage Risks Wegovy Risks GLP-1 Hormone Tirzepatide Side Effects Weight Loss Injections Adverse Reactions Monitoring Semaglutide Ozempic Management Lipohypertrophy

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Regulators are assessing new dosing options following trial results showing greater weight loss with added side effects.